GenIUL Now Licenced to Offer PMA for Viability PCR
It concerns the unique Sub Licensee from QIAGEN for the manufacturing and sales of Propidium Monoazide during an interim period. Nowadays GenIUL is the only company respecting the intellectual property rights related to the use of Propidium Monoazide for viability PCR.
The product is presented in a metallic zip bag with 2 screw cap dark glass vials containing each 0,5 mg of dry PMA: this format is easy to handle and has been specifically developed for viability PCR customers.
Thanks to the agreement with QIAGEN, GenIUL is now the first company that offers this licensed product specifically developed for viability PCR and our current price (ex works) of 80 euro for 1 mg (2x 0.5mg) is highly competitive and moreover also includes the non transferable license rights.
Date Published: September 24, 2012
Source article link: GENIUL, S.L. » company contact details
Bio-Rad Launches a New PCR Kit and Chromogenic Media
Go Beyond TaqMan Specificity - Gain Additional Control With Less Work
Detection of Genetically Modified Salmon in Food and Feed
High-Throughput Solution for Automated DNA/RNA Extraction and PCR Setup
Efficient and Reliable Detection of Beer Spoiling Bacteria in Just an Hour!